184 related articles for article (PubMed ID: 20053138)
1. Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model.
Igarashi T; Miyake K; Masuda I; Takahashi H; Shimada T
Hum Gene Ther; 2010 May; 21(5):631-7. PubMed ID: 20053138
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus type 8 vector-mediated expression of siRNA targeting vascular endothelial growth factor efficiently inhibits neovascularization in a murine choroidal neovascularization model.
Igarashi T; Miyake N; Fujimoto C; Yaguchi C; Iijima O; Shimada T; Takahashi H; Miyake K
Mol Vis; 2014; 20():488-96. PubMed ID: 24744609
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization.
El Sanharawi M; Touchard E; Benard R; Bigey P; Escriou V; Mehanna C; Naud MC; Berdugo M; Jeanny JC; Behar-Cohen F
Gene Ther; 2013 Nov; 20(11):1093-103. PubMed ID: 23804076
[TBL] [Abstract][Full Text] [Related]
4. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE
Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462
[TBL] [Abstract][Full Text] [Related]
5. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
[TBL] [Abstract][Full Text] [Related]
6. A Hypoxia-Regulated Retinal Pigment Epithelium-Specific Gene Therapy Vector Reduces Choroidal Neovascularization in a Mouse Model.
Yuan Y; Kong W; Liu XM; Shi GH
Curr Gene Ther; 2022; 22(5):417-426. PubMed ID: 35382718
[TBL] [Abstract][Full Text] [Related]
7. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.
Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW
Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
[TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
Lai CC; Wu WC; Chen SL; Xiao X; Tsai TC; Huan SJ; Chen TL; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2401-7. PubMed ID: 11527956
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
11. The possibility of gene therapy for the treatment of choroidal neovascularization.
Murata T; Cui J; Taba KE; Oh JY; Spee C; Hinton DR; Ryan SJ
Ophthalmology; 2000 Jul; 107(7):1364-73. PubMed ID: 10889114
[TBL] [Abstract][Full Text] [Related]
12. Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys.
Lai CM; Shen WY; Brankov M; Lai YK; Barnett NL; Lee SY; Yeo IY; Mathur R; Ho JE; Pineda P; Barathi A; Ang CL; Constable IJ; Rakoczy EP
Mol Ther; 2005 Oct; 12(4):659-68. PubMed ID: 16023893
[TBL] [Abstract][Full Text] [Related]
13. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial.
Rakoczy EP; Lai CM; Magno AL; Wikstrom ME; French MA; Pierce CM; Schwartz SD; Blumenkranz MS; Chalberg TW; Degli-Esposti MA; Constable IJ
Lancet; 2015 Dec; 386(10011):2395-403. PubMed ID: 26431823
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Injection of AAV Expressing Soluble VEGF Receptor-1 Variant Induces Anti-VEGF Activity and Suppresses Choroidal Neovascularization.
Lee SHS; Kim HJ; Shin OK; Choi JS; Kim J; Cho YH; Ha J; Park TK; Lee JY; Park K; Lee H
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5398-5407. PubMed ID: 30452593
[TBL] [Abstract][Full Text] [Related]
16. A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.
Li Y; Zhu P; Verma A; Prasad T; Deng H; Yu D; Li Q
J Cell Mol Med; 2017 Aug; 21(8):1555-1571. PubMed ID: 28332318
[TBL] [Abstract][Full Text] [Related]
17. Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization.
Owen LA; Uehara H; Cahoon J; Huang W; Simonis J; Ambati BK
PLoS One; 2012; 7(3):e33576. PubMed ID: 22438952
[TBL] [Abstract][Full Text] [Related]
18. Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.
Lambert NG; Zhang X; Rai RR; Uehara H; Choi S; Carroll LS; Das SK; Cahoon JM; Kirk BH; Bentley BM; Ambati BK
Exp Eye Res; 2016 Apr; 145():248-257. PubMed ID: 26775053
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins.
Murakami Y; Ikeda Y; Yonemitsu Y; Miyazaki M; Inoue M; Hasegawa M; Sueishi K; Ishibashi T
Hum Gene Ther; 2010 Feb; 21(2):199-209. PubMed ID: 19778186
[TBL] [Abstract][Full Text] [Related]
20. Correlation of in vivo and in vitro methods in measuring choroidal vascularization volumes using a subretinal injection induced choroidal neovascularization model.
Nie C; Zhang MN; Zhao HW; Olsen TD; Jackman K; Hu LN; Ma WP; Chen XF; Wang J; Zhang Y; Gao TS; Uehara H; Ambati BK; Luo L
Chin Med J (Engl); 2015 Jun; 128(11):1516-22. PubMed ID: 26021510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
